Cargando…

HDAC6 Deficiency Has Moderate Effects on Behaviors and Parkinson’s Disease Pathology in Mice

Histone deacetylase 6 (HDAC6) is involved in the regulation of protein aggregation and neuroinflammation, but its role in Parkinson’s disease (PD) remains controversial. In this study, Hdac6(−/−) mice were generated by CRISPR-Cas9 technology for exploring the effect of HDAC6 on the pathological prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jiayin, He, Yongtao, Duan, Yufei, Ma, Yuanyuan, Dong, Hongtian, Zhang, Xiaoshuang, Fang, Rong, Zhang, Yunhe, Yu, Mei, Huang, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298689/ https://www.ncbi.nlm.nih.gov/pubmed/37373121 http://dx.doi.org/10.3390/ijms24129975

Ejemplares similares

Deficiency of miR-29b2/c leads to accelerated aging and neuroprotection in MPTP-induced Parkinson’s disease mice
por: Bai, Xiaochen, et al.
Publicado: (2021)

Deficiency of miR-29a/b1 leads to premature aging and dopaminergic neuroprotection in mice
por: Bai, Xiaochen, et al.
Publicado: (2022)

NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson’s disease models
por: Liu, Zhaolin, et al.
Publicado: (2023)

Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson’s disease
por: Li, Qing, et al.
Publicado: (2021)

Pro-survival and anti-inflammatory roles of NF-κB c-Rel in the Parkinson's disease models
por: Wang, Zishan, et al.
Publicado: (2020)

TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson’s disease
por: Shao, Qian-hang, et al.
Publicado: (2019)

Synthesis and Biological Evaluation of HDAC Inhibitors With a Novel Zinc Binding Group
por: He, Junquan, et al.
Publicado: (2020)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
por: Thomas, Elizabeth A.
Publicado: (2014)

Pathological Role of HDAC8: Cancer and Beyond
por: Kim, Ji Yoon, et al.
Publicado: (2022)

Case Report of a pathologically confirmed vascular parkinsonism with early cognitive impairment and Behavioral disturbance
por: Zhang, Shouzi, et al.
Publicado: (2021)

Phospho-HDAC6 Gathers Into Protein Aggregates in Parkinson’s Disease and Atypical Parkinsonisms
por: Mazzetti, Samanta, et al.
Publicado: (2020)

Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington’s Disease Pathology
por: Macabuag, Natsuko, et al.
Publicado: (2022)

Deficient immunoproteasome assembly drives gain of α-synuclein pathology in Parkinson's disease
por: Bi, Mingxia, et al.
Publicado: (2021)

Moderately differentiated esophageal squamous cell carcinoma has a poor prognosis after neoadjuvant chemoradiotherapy
por: He, Wenwu, et al.
Publicado: (2021)

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma
por: Huang, Renhong, et al.
Publicado: (2018)

Phosphatidylserine improves axonal transport by inhibition of HDAC and has potential in treatment of neurodegenerative diseases
por: Naftelberg, Shiran, et al.
Publicado: (2017)

The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
por: Dewanjee, Saikat, et al.
Publicado: (2021)

Targeting the HDAC6‐Cilium Axis Ameliorates the Pathological Changes Associated with Retinopathy of Prematurity
por: Ran, Jie, et al.
Publicado: (2022)

E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors
por: Decourtye-Espiard, Lyvianne, et al.
Publicado: (2021)

Tau Pathology in Parkinson's Disease
por: Zhang, Xue, et al.
Publicado: (2018)

HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma
por: Shen, Chen, et al.
Publicado: (2023)

Brain-specific NRSF deficiency aggravates dopaminergic neurodegeneration and impairs neurogenesis in the MPTP mouse model of Parkinson’s disease
por: Huang, Dongping, et al.
Publicado: (2019)

JAK-STAT Pathway Inhibition Partially Restores Intestinal Homeostasis in Hdac1- and Hdac2-Intestinal Epithelial Cell-Deficient Mice
por: Gonneaud, Alexis, et al.
Publicado: (2021)

The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer’s disease
por: Yang, Shuang-shuang, et al.
Publicado: (2017)

Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
por: Seo, Jinwon, et al.
Publicado: (2014)

Patients with Parkinson’s disease predict a lower incidence of colorectal cancer
por: Fang, Hongsheng, et al.
Publicado: (2021)

Novel hybrid molecule overcomes the limited response of solid tumours to HDAC inhibitors via suppressing JAK1-STAT3-BCL2 signalling
por: Huang, Zhi, et al.
Publicado: (2018)

HDAC Inhibitors Correct Frataxin Deficiency in a Friedreich Ataxia Mouse Model
por: Rai, Myriam, et al.
Publicado: (2008)

Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia-telangiectasia
por: Li, Jiali, et al.
Publicado: (2012)

Aquaporin‐4 deficiency reduces TGF‐β1 in mouse midbrains and exacerbates pathology in experimental Parkinson's disease
por: Xue, Xue, et al.
Publicado: (2019)

Wogonin Has Multiple Anti-Cancer Effects by Regulating c-Myc/SKP2/Fbw7α and HDAC1/HDAC2 Pathways and Inducing Apoptosis in Human Lung Adenocarcinoma Cell Line A549
por: Chen, Xin-mei, et al.
Publicado: (2013)

The Transcription Factor NRF2 Has Epigenetic Regulatory Functions Modulating HDACs, DNMTs, and miRNA Biogenesis
por: Silva-Llanes, Ignacio, et al.
Publicado: (2023)

Pathology of Bursae of Fabricius in Methionine-Deficient Broiler Chickens
por: Wu, Bangyuan, et al.
Publicado: (2013)

Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study
por: Lu, Dong-cheng, et al.
Publicado: (2022)

Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient rats
por: Lamberty, Benjamin G., et al.
Publicado: (2023)

HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression
por: Zhang, Lijun, et al.
Publicado: (2023)

HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases
por: Yoon, Somy, et al.
Publicado: (2016)

The association between HDAC9 gene polymorphisms and stroke risk in the Chinese population: A meta-analysis
por: Zhou, Xin, et al.
Publicado: (2017)

HDAC6 and Ovarian Cancer
por: Haakenson, Joshua, et al.
Publicado: (2013)

HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage
por: Kim, Jin Young, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_kjndhf3ajf88j3ta2n6t1u3jov